Drug prices in Russia may increase by 20%-25% due to new labelling requirements

Drug prices in Russia may increase by 20%-25% this year, due to the implementation of the latest state initiative for the introduction of mandatory QR-labelling on drugs in the local market, according to recent statements by local producers and analysts in the field of pharmaceutics, reports The Pharma Letrer’s local correspondent.

A pilot project was launched on February 1, and the new labeling requirements will become mandatory starting from January 1, 2018.

This has already sparked concerns from drugmakers and local pharmacy chains, according to which the new state initiative may result in a significant sales decline.